• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNKNOWN
Device Problem Entrapment of Device (1212)
Patient Problem Rupture (2208)
Event Date 02/16/2020
Event Type  Injury  
Manufacturer Narrative
The onyx will not be returned for evaluation as it was consumed in the event.  based on the reported information, there did not appear to have been any defect of the device during use.This is procedure related event.Related mdrs for this event: 2029214-2020-00288.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that apollo catheter separated as it was difficult to remove from the onyx cast.This patient has had multiple treatments in radiology to address his large cerebral arteriovenous malformation (avm).First presentation was when it ruptured.This case was to embolize another feeder that had not previously been treated.The inr was unwilling to pull the microcatheter out while he had no visibility but the 7-minute delay in rebooting the machines meant the catheter became difficult to remove from the onyx cast.Aspiration on the syringe and traction were unsuccessful.Strong traction resulted in the catheter broke/ separated about 10cm from the tip, and resulted in a rupture of the feeding vessel, which was treated effectively with coils.The device and the accessory devices were prepared as indicated in the instructions for use (ifu).There was no resistance when the onyx was used.0.1 ml per minute was the injection rate.The vessel anatomy was moderate in tortuosity.The patient was asymptomatic post the intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
katcha taylor
9775 toledo way
irvine, CA 92618
9496801345
MDR Report Key9872465
MDR Text Key195544418
Report Number2029214-2020-00289
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 03/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Lot NumberNOT REPORTED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/04/2020
Initial Date FDA Received03/24/2020
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age37 YR
-
-